Tacrolimus Sandoz 0,5 mg, capsules, hard

국가: 네덜란드

언어: 네덜란드어

출처: CBG-MEB (College ter Beoordeling van Geneesmiddelen)

지금 구매하세요

환자 정보 전단 환자 정보 전단 (PIL)
21-09-2022
제품 특성 요약 제품 특성 요약 (SPC)
27-07-2022

유효 성분:

TACROLIMUS 1-WATER 0,511 mg/stuk SAMENSTELLING overeenkomend met ; TACROLIMUS 0-WATER 0,5 mg/stuk

제공처:

Sandoz B.V. Veluwezoom 22 1327 AH ALMERE

ATC 코드:

L04AD02

INN (International Name):

TACROLIMUS 1-WATER 0,511 mg/stuk SAMENSTELLING overeenkomend met ; TACROLIMUS 0-WATER 0,5 mg/stuk

약제 형태:

Capsule, hard

구성:

CROSCARMELLOSE NATRIUM (E 468) ; GELATINE (E 441) ; HYPROMELLOSE (E 464) ; IJZEROXIDE GEEL (E 172) ; LACTOSE 1-WATER ; MAGNESIUMSTEARAAT (E 470b) ; NATRIUMLAURILSULFAAT ; SORBITANMONOLAURAAT (E 493) ; TITAANDIOXIDE (E 171), CROSCARMELLOSE NATRIUM (E 468) ; GELATINE (E 441) ; HYPROMELLOSE (E 464) ; IJZEROXIDE GEEL (E 172) ; LACTOSE 1-WATER ; MAGNESIUMSTEARAAT (E 470b) ; NATRIUMLAURILSULFAAT (E 487) ; SORBITANMONOLAURAAT (E 493) ; TITAANDIOXIDE (E 171),

관리 경로:

Oraal gebruik

치료 영역:

Tacrolimus

제품 요약:

Hulpstoffen: CROSCARMELLOSE NATRIUM (E 468); GELATINE (E 441); HYPROMELLOSE (E 464); IJZEROXIDE GEEL (E 172); LACTOSE 1-WATER; MAGNESIUMSTEARAAT (E 470b); NATRIUMLAURILSULFAAT (E 487); SORBITANMONOLAURAAT (E 493); TITAANDIOXIDE (E 171);

승인 날짜:

2009-12-22

환자 정보 전단

                                Sandoz B.V.
Page 1
Tacrolimus Sandoz 0,5 mg, 0,75 mg, 1 mg, 2
mg, 5 mg, capsules, hard
RVG 102096/113454/102097/113453/102098
1313-v14
1.3.1.3 Bijsluiter
Mei 2022
BIJSLUITER: INFORMATIE VOOR DE PATIËNT
TACROLIMUS SANDOZ® 0,5 MG, CAPSULES, HARD
TACROLIMUS SANDOZ® 0,75 MG, CAPSULES, HARD
TACROLIMUS SANDOZ® 1 MG, CAPSULES, HARD
TACROLIMUS SANDOZ® 2 MG, CAPSULES, HARD
TACROLIMUS SANDOZ® 5 MG, CAPSULES, HARD
tacrolimus
_ _
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
−
Keep this leaflet. You may need to read it again.
−
If you have any further questions, ask your doctor or pharmacist.
−
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm
them, even if their signs of illness are the same as yours.
−
If you get any side effects, talk to your doctor or pharmacist. This
includes any possible
side effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What [Nationally completed name] is and what it is used for
2.
What you need to know before you take [Nationally completed name]
3.
How to take [Nationally completed name]
4.
Possible side effects
5.
How to store [Nationally completed name]
6.
Contents of the pack and other information
1.
WHAT [NATIONALLY COMPLETED NAME] IS AND WHAT IT IS USED FOR
[Nationally completed name] belongs to a group of medicines called
IMMUNOSUPPRESSANTS
.
Following your organ transplant (e.g. liver, kidney, heart), your
body’s immune system will
try to reject the new organ.
[Nationally completed name] is used to control your body’s immune
response enabling your
body to accept the transplanted organ. [Nationally completed name] is
often used in
combination with other medicines that also suppress the immune system.
You may also be given [Nationally completed name] for an ongoing
rejection of your
transplanted liver, kidney, heart or other organ or if any previous
treatment you were taking
was unable to control this immune response after your tra
                                
                                전체 문서 읽기
                                
                            

제품 특성 요약

                                Sandoz B.V.
Page 1
Tacrolimus Sandoz 0,5 mg, 0,75 mg, 1 mg, 2 mg, 5 mg, capsules, hard
RVG 102096, 113454, 102097, 113453, 102098
1311-v15
1.3.1.1 Summary of Product Characteristics
Mei 2022
1
NAAM VAN HET GENEESMIDDEL
Tacrolimus Sandoz 0,5 mg, capsules, hard
Tacrolimus Sandoz 0,75 mg, capsules, hard
Tacrolimus Sandoz 1 mg, capsules, hard
Tacrolimus Sandoz 2 mg, capsules, hard
Tacrolimus Sandoz 5 mg, capsules, hard
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each hard capsule contains 0.5 mg of tacrolimus (as tacrolimus
monohydrate).
Excipient with known effect:
Each hard capsule contains 46.1 mg lactose (as monohydrate).
Each hard capsule contains 0.75 mg of tacrolimus (as tacrolimus
monohydrate).
Excipient with known effect:
Each hard capsule contains 69.1 mg lactose (as monohydrate).
Each hard capsule contains 1 mg of tacrolimus (as tacrolimus
monohydrate).
Excipient with known effect:
Each hard capsule contains 45.0 mg lactose (as monohydrate).
Each hard capsule contains 2 mg of tacrolimus (as tacrolimus
monohydrate).
Excipient with known effect:
Each hard capsule contains 90.0 mg lactose (as monohydrate).
Each hard capsule contains 5 mg of tacrolimus (as tacrolimus
monohydrate).
Excipient with known effect:
Each hard capsule contains 225.1 mg lactose (as monohydrate).
For the full list of excipients, see section 6.1.
3
PHARMACEUTICAL FORM
Sandoz B.V.
Page 2
Tacrolimus Sandoz 0,5 mg, 0,75 mg, 1 mg, 2 mg, 5 mg, capsules, hard
RVG 102096, 113454, 102097, 113453, 102098
1311-v15
1.3.1.1 Summary of Product Characteristics
Mei 2022
Capsule, hard
_0.5 mg hard capsules _
Opaque white and ivory hard gelatin capsule containing white to off-
white powder (length: 14.5 mm).
_0.75 mg hard capsules _
Light green opaque hard gelatin capsule, imprinted in black with 0.75
mg on the cap, containing white
to off-white powder (length: 14.5 mm).
_1 mg hard capsules _
Opaque white and light brown hard gelatin capsule containing white to
off- white powder (length:
14.5 mm).
_2 mg hard capsules _
Dark green opaque capsule, imprinted
                                
                                전체 문서 읽기